Skip to main content

Amundi

Position in LLY — ELI LILLY & Co

CIK 1330387 Paris, I0

Position in LLY

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$4,649,460,337
-$294,579,662 QoQ
Shares Held
5,055,025
+9.9% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 99.19654205468815.ToString("F0")% Shared 0.08528147734185292.ToString("F0")% None 0.7181764679699902.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Amundi holds $19,301,385,364 across 13 Drug Manufacturers - General names. LLY ranks #1 (24.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
5,055,025 $4,649,460,337

All Filings in LLY

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,649,460,337 5,055,025
2025-12-31 $4,944,039,999 4,600,476
2025-09-30 $3,453,263,226 4,525,902
2025-06-30 $2,776,083,277 3,561,227
2025-03-31 $4,090,837,929 4,953,128
2024-12-31 $3,388,169,812 4,388,821
2024-09-30 $4,021,891,171 4,539,688
2024-06-30 $3,614,538,596 3,992,289
2024-03-31 $3,162,976,070 4,065,731
2023-12-31 $2,184,583,040 3,747,655
2023-09-30 $2,364,292,091 4,401,713
2023-06-30 $2,282,695,887 4,867,363
2023-03-31 $1,951,591,630 5,682,813
2022-12-31 $1,669,701,429 4,564,021
2022-09-30 $1,592,413,052 4,924,735
2022-06-30 $1,221,123,767 3,766,227
2022-03-31 $1,068,743,423 3,732,037
2021-12-31 $949,679,979 3,438,129
2021-09-30 $832,583,819 3,603,479
2021-06-30 $1,008,577,879 4,394,292